FARALLON CAPITAL MANAGEMENT LLC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 81 filers reported holding REPROS THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q1 2015$1,718,000
-42.6%
200,000
-33.3%
0.02%
-39.0%
Q4 2014$2,991,000
-56.8%
300,000
-57.1%
0.04%
-63.1%
Q3 2014$6,930,000
-42.8%
700,0000.0%0.11%
-36.6%
Q2 2014$12,110,000
-2.5%
700,0000.0%0.18%
-28.3%
Q1 2014$12,418,000
-3.1%
700,0000.0%0.24%
-7.9%
Q4 2013$12,810,000
+1.7%
700,000
+48.9%
0.26%
+2.7%
Q3 2013$12,596,000
+59.5%
470,000
+9.8%
0.26%
+70.9%
Q2 2013$7,897,000428,0000.15%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 778,800$935,0000.18%
Allegis Investment Advisors, LLC 366,190$439,0000.12%
GENERAL AMERICAN INVESTORS CO INC 589,768$708,0000.07%
Acrospire Investment Management LLC 24,881$30,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 114,165$137,0000.00%
Mariner Wealth Advisors-Cincinnati, LLC 11,000$13,0000.00%
Renaissance Technologies 727,113$873,0000.00%
BALDWIN BROTHERS LLC/MA 1,750$2,0000.00%
VANGUARD GROUP INC 889,850$1,068,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 150$00.00%
View complete list of REPROS THERAPEUTICS INC shareholders